💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadExplore for free

BRIEF-DiagnoCure executes asset purchase agreement

Published 2015-12-23, 05:27 p/m
© Reuters.  BRIEF-DiagnoCure executes asset purchase agreement
CUR
-

Dec 23 (Reuters) - DiagnoCure Inc CUR.TO :
* Press release - Diagnocure announces the execution of an asset purchase
agreement
* Says transaction to include selling assets associated with pca3 to Hologic
Inc,
* Transaction to include repurchase of preferred shares held by gen-probe
incorporated
* Deal for C$6.5 million
* Says gen-probe has agreed to acquire all assets related to diagnocure's pca3
prostate cancer biomarker for CAD$6.5 million
* Says corporation will distribute following closing of transaction
approximately 95% of proceeds received to shareholders

* Source text for Eikon ID:nPnVwYdL

* Further company coverage CUR.TO

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.